Oncolytic Virus (rHSV) Pipeline
Pipeline
Developing Products
That Are Potent, Enabling,
Novel and Safe
That Are Potent, Enabling,
Novel and Safe
-
Product
Indication
Drug
DiscoveryPre-clinical
IND
Phase I
Phase II
Phase III
BLA
Commer-cialization
-
MVR-T3011 IT
MVR-T3011 IT
MVR-T3011 IT
Combo PD-1MVR-T3011 IT
MVR-T3011 IV
MVR-T3011 IV
MVR-T3011 IP
MVR-C5252
MVR-C5252
HNSCC
HNSCC
HNSCC
Melanoma
Most Solids
Most Solids
Bladder
GBM
GBM
US Phase IIa，FDA Fast Track ReviewChina Phase IIaChina Phase Ib/IIaChina Phase llaUS Phase IChina Phase lChina/US Phase IIUS Phase l,FDA Orphan DrugChina IND Approved
-
Various Administration
Methods
Intravenous
Intratumoral
Intraperitoneal,
intrapleural,
intravesical
Multi-regional Clinical Trials
Clinical trials are the research studies intended to find out if a new treatment is safe and provides better outcomes than the existing standard of care–the best available known treatment. You can find more information about our ongoing clinical trials below.
Biomarker
Biomarker kit to assess the efficacy of OV products and pre-screen potential patients for oHSV clinical treatment
-
Platform
Product
R&D/Pilot test/Manufacturing
Drug Quality Control
Clinical Trials
Registration
Approval
-
Biomarker Program
Biomarker Kit
